Sanofi’s Evolutive Vaccine Facility will be built around a central unit that contains several digital production modules that can manufacture three to four vaccines at the same time. The facility, which will be located in Neuville sur Saône, France, is expected to create about 200 new jobs.
The research and development center will be built at Sanofi’s site in Marcy-l’Etoile, France. It will include laboratories for new vaccine development as the company seeks greater preparedness for future disease outbreaks.
More articles on pharmacy:
10 exec moves affecting the pharma industry
Ohio Medicaid to pay pharmacies to give COVID-19 tests
US appeals court strikes down HHS rule requiring drug prices in TV ads
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
